HIGHLIGHTS
- who: Avneesh K. Singh and collaborators from the Department of Surgery, School of Medicine, University of Maryland, Baltimore, MD, United States, Revivicor Inc, Blacksburg have published the article: Cardiac Xenotransplantation: Progress in Preclinical Models and Prospects for Clinical Translation, in the Journal: (JOURNAL)
SUMMARY
Xenotransplantation (XTx) is an alternative source of a human organ for patients with end-stage organ failure. While preformed antibody responses dominate Gal antigens, it has been shown that elicited Abs responses can occur in cardiac XTx also towards these other antigens (i.e., non-Gal antigens). Cellular Xenograft . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.